| Net sales | 10,636a | 10,360a | 10,057a |
| Cost of sales | -6,652a | -6,210a | -6,508a |
| Gross margin | 3,984a | 4,150a | 3,549a |
| Selling, general and administrative expenses | -2,967a | -2,953a | -3,097a |
| Research and development expenses | -590a | -518a | -450a |
| Goodwill impairments | -425a | 0a | -2,812a |
| Other operating expense (income), net | -12a | -28a | 35a |
| Operating income (loss) | 14a | 707a | -2,845a |
| Interest expense, net | -341a | -439a | -394a |
| Other (income) expense, net | -38a | 26a | 9a |
| Income (loss) from continuing operations before income taxes | -289a | 242a | -3,248a |
| Income tax (benefit) expense | -37a | -61a | -135a |
| Income (loss) from continuing operations | -326a | 181a | -3,113a |
| Income (loss) from discontinued operations, net of tax | -312a | 2,482a | 692a |
| Net income (loss) | -638a | 2,663a | -2,421a |
| Less: net income attributable to noncontrolling interests included in continuing operations | 0a | 0a | 1a |
| Less: net income attributable to noncontrolling interests included in discontinued operations | 11a | 7a | 11a |
| Net income (loss) attributable to Baxter stockholders | -649a | 2,656a | -2,433a |